This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015;83(4):280-1.

doi: 10.1159/000374114. Epub 2015 Mar 6.

How aggressively should we treat short stature?

Ron G Rosenfeld¹

Affiliations

PMID: 25765056
DOI: 10.1159/000374114

Free article

Comment

How aggressively should we treat short stature?

Ron G Rosenfeld. Horm Res Paediatr. 2015.

Free article

. 2015;83(4):280-1.

doi: 10.1159/000374114. Epub 2015 Mar 6.

Author

Ron G Rosenfeld¹

Affiliation

¹ Oregon Health and Science University, Portland, Oreg., and STAT5 LLC, Los Altos, Calif., USA.

PMID: 25765056
DOI: 10.1159/000374114

No abstract available

PubMed Disclaimer

Comment on

Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA; MS316 Study Group. Backeljauw PF, et al. Horm Res Paediatr. 2015;83(4):268-79. doi: 10.1159/000371799. Epub 2015 Mar 6. Horm Res Paediatr. 2015. PMID: 25765099 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- S. Karger AG, Basel, Switzerland
Medical
- MedlinePlus Health Information